Why Cardiovascular Perfusion Is the Most Mismanaged Cost Center in Your Hospital

Walk into almost any hospital CFO's office and ask about supply chain costs — you'll get a detailed breakdown within minutes. Ask about cardiovascular perfusion disposables per case, and you'll likely get a pause, a call to the OR director, and ultimately an estimate that could be off by 30% or more. That knowledge gap is not a small problem. For hospitals performing 300 or more cardiac procedures annually, it can represent hundreds of thousands of dollars in untracked, unmanaged spending.

The Expertise Gap

Cardiovascular perfusion sits at a unique intersection: it is simultaneously a clinical subspecialty requiring highly credentialed professionals and a significant cost center with complex supply, staffing, and equipment dynamics. Most hospital administrators — including many CFOs and COOs — have limited clinical exposure to perfusion, which means they rely almost entirely on the perfusion team or, worse, their perfusion vendor to define what costs are reasonable.

This creates a structural conflict. If your perfusion services are managed by an outside vendor, that vendor has every incentive to define "reasonable" in ways that protect their margin. If managed in-house, the perfusion team may have excellent clinical judgment but limited exposure to benchmarking data across institutions. Either way, leadership rarely has the independent data to push back.

Where the Money Actually Goes

A typical cardiovascular perfusion program has three major cost buckets: disposable supplies, contract labor or vendor fees, and capital equipment and maintenance. Each carries distinct risk.

• Disposable supplies — oxygenators, circuits, cannulas, filters — are often purchased under agreements negotiated years ago without price benchmarking against peer institutions. Per-case supply costs can vary by 40% or more between comparable programs.
• Contract labor and vendor management fees are frequently structured with built-in escalators that most administrators never revisit. A contract signed five years ago may now be 15–25% above market.
• Equipment maintenance agreements are often bundled with capital leases in ways that obscure true cost per use. Institutions frequently overpay for coverage they could obtain independently at lower cost.

The Benchmarking Problem

Unlike many clinical service lines, perfusion lacks a widely used public benchmarking database that administrators can access easily. This means that the primary source of market data is often the vendor — which is like asking a car dealership whether the sticker price is fair. Independent benchmarking, drawing on data from comparable institutions across volume, geography, and program structure, is the only reliable way to establish whether your current spend is appropriate.

In our work with hospitals nationwide, we have found that the average institution is spending 18–24% more than necessary on perfusion-related costs. That figure is not the result of bad intentions — it is the predictable outcome of a cost center that has been allowed to operate without rigorous independent oversight.

What Leadership Can Do Now

• Request a per-case cost breakdown from your OR finance team or perfusion vendor — total supply cost, labor cost, and equipment cost per procedure type.
• Compare your cost per case against published ranges from professional societies such as AMSECT and the Society of Thoracic Surgeons.
• Review the expiration dates and escalator clauses on any perfusion-related vendor contracts currently in force.
• Commission an independent cost analysis before your next contract renewal — not one conducted by the vendor.

The institutions that have addressed this systematically — not through adversarial renegotiation but through informed, data-driven conversations — have consistently achieved meaningful reductions in cost without compromising clinical outcomes. The expertise gap is closable. It begins with acknowledging it exists.